New obesity drug may affect birth control: study underway
NCT ID NCT07525791
First seen Apr 16, 2026 · Last updated Jun 19, 2026 · Updated 13 times
Summary
This early-stage study is testing whether a new weekly injection called NNC0662-0419 changes how birth control pills and a common painkiller work in the body. Researchers will measure drug levels in the blood and stomach emptying in 45 women who cannot become pregnant and have overweight or obesity. The goal is to see if the new drug is safe to take with these other medicines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altasciences Clinical Kansas, Inc.
RECRUITINGOverland Park, Kansas, 66212, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NNC0662-0419
What this could lead to
If successful, this study could show that NNC0662-0419 is safe to use with birth control pills, helping women with overweight or obesity avoid unintended pregnancies.
What could go wrong
This is an early Phase 1 trial with only 45 participants, so results may not apply to everyone. The study focuses on drug interactions, not weight loss or other benefits.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.